(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(0.33%) $79.25
(-0.27%) $2.18
(-0.28%) $2 315.80
(-0.22%) $27.54
(-0.02%) $984.40
(0.06%) $0.931
(0.08%) $10.90
(0.06%) $0.801
(0.02%) $91.76
Live Chart Being Loaded With Signals
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite...
Stats | |
---|---|
本日の出来高 | 1.08M |
平均出来高 | 1.60M |
時価総額 | 12.50B |
EPS | INR0 ( 2024-02-14 ) |
次の収益日 | ( INR0 ) 2024-05-27 |
Last Dividend | INR0 ( N/A ) |
Next Dividend | INR0 ( N/A ) |
P/E | 38.00 |
ATR14 | INR0.0410 (0.31%) |
ボリューム 相関
Syncom Formulations 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
Syncom Formulations 相関 - 通貨/商品
Syncom Formulations 財務諸表
Annual | 2022 |
収益: | INR2.24B |
総利益: | INR825.58M (36.81 %) |
EPS: | INR0.220 |
FY | 2022 |
収益: | INR2.24B |
総利益: | INR825.58M (36.81 %) |
EPS: | INR0.220 |
FY | 2022 |
収益: | INR2.18B |
総利益: | INR709.74M (32.58 %) |
EPS: | INR0.240 |
FY | 2021 |
収益: | INR2.39B |
総利益: | INR722.43M (30.19 %) |
EPS: | INR0.380 |
Financial Reports:
No articles found.
Syncom Formulations
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It offers various products, including generics, alpha adrenoceptor agonists, analgesics, antipyretics, anti-inflammatory, anti-ulcer agents, antibiotics, antidepressants, antifungals, antihistamines, antimalarial, antiplatelet agents, antiprotozoal, antivirals, bronchodilators, calcium antagonists, cardiac medicines, central nervous stimulants, cephelo sporins, cortico steroids, estrogen, cough suppressants, erectile dysfunction, and electrolite. The company also provides histamines, homeostatic, hypoglycemic, hypolipidaemics, local anesthetics, multivitamins and nutritional supplements, sedative anticonvulsants, stimulants, and sympathomimetic products, as well as products used in the treatment of gout. In addition, it engages in the trading of commodities and renting of properties. Further, the company exports its products. It offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, liquids orals, liquid vials, ampoule injections and dry vial injections, dry syrups, ointments, inhalers, and herbals. Syncom Formulations (India) Limited was founded in 1985 and is based in Indore, India.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。